NaturalShrimp Incorporated (SHMP)
| Previous close | 0.0093 |
| Open | 0.0094 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0090 - 0.0100 |
| 52-week range | 0.0090 - 0.0600 |
| Volume | |
| Avg. volume | 6,281,701 |
| Market cap | 8.778M |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | 0.95 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Natural Shrimp E-Commerce Update
Natural Shrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), announces that it has launched its online ordering home delivery website at www.naturalshrimpharvest-select.com, including a new dedicated fulfilment center with an upgraded ordering process.
- PR Newswire
Natural Shrimp, Inc. Announces New Markets for Sale of Shrimp
Natural Shrimp, Incorporated. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced that, as a result of significantly increased production at its Webster City facility, the Company is in the process of identifying, contacting and securing new commercial outlets for the sale of the Company's sushi grade shrimp.
- PR Newswire
Natural Shrimp, Inc. Completes Successful Trial in Japan
Natural Shrimp, Inc. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced it has completed at the end of February 2024 a successful 6-month trial in Japan with the Company's patented Electrocoagulation (EC) and Hydrogas™ technologies (the "Equipment").
